» Articles » PMID: 16272350

The Role of Complement in Cryoglobulin-induced Immune Complex Glomerulonephritis

Overview
Journal J Immunol
Date 2005 Nov 8
PMID 16272350
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Many forms of glomerulonephritis are triggered by Ab localization in the glomerulus, but the mechanisms by which this induces glomerular inflammation are not fully understood. In this study we investigated the role of complement in a mouse model of cryoglobulin-induced immune complex glomerulonephritis. Several complement-deficient mice on a C57BL/6 and BALB/c genetic background were used and compared with strain-matched, wild-type controls. Cryoglobulinemia was induced by i.p. injection of 6-19 hybridoma cells producing an IgG3 cryoglobulin with rheumatoid factor activity against IgG2a of allotype a present in BALB/c, but not C57BL/6, mice. Thus, the cryoprecipitate in C57BL/6 mice consisted of the IgG3 cryoglobulin only (type I cryoglobulinemia) compared with IgG3-IgG2a complexes in BALB/c (type II cryoglobulinemia). The survival of mice was not affected by complement deficiency. Glomerular influx of neutrophils was significantly less in C3-, factor B-, and C5-deficient mice compared with wild-type and C1q-deficient mice. It did not correlate with C3 deposition, but did correlate with the amount of C6 deposited. Deficiency of CD59a, the membrane inhibitor of the membrane attack complex, did not induce an increase in neutrophil infiltration, suggesting that the generation of C5a accounts for the effects observed. There was no apparent difference between cryoglobulinemia types I and II regarding the role of complement. Our results suggest that in this model of cryoglobulin-induced glomerulonephritis the neutrophil influx was mediated by C5 activation with the alternative pathway playing a prominent role in its cleavage. Thus, blocking C5 is a potential therapeutic strategy for preventing renal injury in cryoglobulinemia.

Citing Articles

C1q as a target molecule to treat human disease: What do mouse studies teach us?.

Schulz K, Trendelenburg M Front Immunol. 2022; 13:958273.

PMID: 35990646 PMC: 9385197. DOI: 10.3389/fimmu.2022.958273.


The Rational Use of Complement Inhibitors in Kidney Diseases.

Fakhouri F, Schwotzer N, Golshayan D, Fremeaux-Bacchi V Kidney Int Rep. 2022; 7(6):1165-1178.

PMID: 35685323 PMC: 9171628. DOI: 10.1016/j.ekir.2022.02.021.


Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis.

Macagno M, Bandini S, Bolli E, Bello A, Riccardo F, Barutello G Biomedicines. 2022; 10(2).

PMID: 35203439 PMC: 8869482. DOI: 10.3390/biomedicines10020230.


The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.

Muro K, Toda N, Yamamoto S, Yanagita M Intern Med. 2020; 60(4):583-589.

PMID: 32999232 PMC: 7946495. DOI: 10.2169/internalmedicine.5461-20.


Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis.

Avalle L, Marino F, Camporeale A, Guglielmi C, Viavattene D, Bandini S Mol Ther Methods Clin Dev. 2020; 18:62-72.

PMID: 32577433 PMC: 7301178. DOI: 10.1016/j.omtm.2020.05.023.